Main Article Content


Approximately 20-30% of all cervical cancer cases are adenocarcinoma and adenosquamous carcinoma. Around 70% of all of these types of cancer are related to infection of Human Papillomavirus (HPV). This study evaluated the distribution of HPV genotype in cervical adenocarcinoma and adenosquamous carcinoma. A cross-sectional study was conducted at the Department of Anatomic Pathology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from January to December 2015. The sample were 22 formalin-fixed paraffin-embedded (FFPE) of cervical adenocarcinoma tissues and adenosquamous carcinoma tissues. FFPE was used for DNA extraction and followed with HPV genotyping to detect 40 genotypes of HPV, including low risk (LR) and high risk (HR) HPV. The histopathological types of adenocarcinomas were adenocarcinoma NOS and mucinous adenocarcinoma, while the adenosquamous carcinoma types were adenosquamous carcinoma and adenosquamous carcinoma glassy. All of the specimens were infected by HPV. In cervical adenocarcinoma, the infection was by HPV 6, 11, 16, 18, 31, 45, 68B, and 72, and in adenosquamous carcinoma by HPV 6, 16, 18, 45, and 59. HPV 18 was predominant, which was found in 13/22 (59.1%) in adenocarcinoma and 19/22 (86.4%) in adenosquamous carcinoma. Single infection and multiple infections in adenocarcinoma were 13/22 (59.1%) and 9/22 (40.9%), while in adenosquamous carcinoma were 21/22 (95.5%) and 1/22 (4.5%) respectively. The most common HR HPVs found in this study were HPV 18, HPV 45, HPV 16 and LR HPV are HPV 11, HPV 6.


human papillomavirus cervical cancer cervical adenocarcinoma cervical adenosquamous carcinoma

Article Details

How to Cite
Mastutik, G., Rahniayu, A., Kurniasari, N., Rahaju, A. S., & Harjanto, B. (2021). Distribution of Human Papilloma Virus (HPV) in Cervical Adenocarcinoma and Adenosquamous Carcinoma. Folia Medica Indonesiana, 57(2), 170–176.


  1. Arbyn M, Weiderpass E, Bruni L, et al (2020). Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health 8, e191-e203
  2. Bray F, Carstensen B, Møller H, et al (2005). Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 14, 2191-9.
  3. Bray F, Ferlay J, Soerjomataram I, et al (2018). GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424
  4. Globocan (2020a). The Global Cancer Observatory 2020. International Agency for Research on Cancer. Available from Accessed March 23, 2021.
  5. Globocan (2020b). The Global Cancer Observatory 2020. International Agency for Research on Cancer: Indonesia. Available from Accessed March 23, 2021.
  6. Fujiwara K, Monk B, Devouassoux-Shisheboran M (2014). Adenocarcinoma of the uterine cervix: why is it different? Curr Oncol Rep 16, 1-9.
  7. Georgescu MT, Georgescu DE, Georgescu TF, et al (2020). Changing the prognosis of metastatic cervix uteri adenosquamous carcinoma through a multimodal approach: A case report. Case Rep Oncol 13, 1545-51.
  8. Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: A unique cervical cancer. Gynecol Oncol 116, 140-6.
  9. Gutiérrez-Xicoténcatl L, Plett-Torres T, Madrid-González CL, et al (2009). Molecular diagnosis of human papillomavirus in the development of cervical cancer. Salud Publica de Mexico 51, S479-88.
  10. Izadi-Mood N, Asadi K, Shojaei H, et al (2012). Potential diagnostic value of P16 expression in premalignant and malignant cervical lesions. J Res Med Sci 17, 428-33
  11. Kurman RJ, Ellenson LH, Ronnett BM (Eds.) (2011). Blaustein’s pathology of the female genital tract, New York, Springer-Verlug, p 253-303.
  12. Mastutik G, Alia R, Rahniayu A, et al (2018). Genotype human pappilomavirus in cervical precancerous lesion and squamous cell carcinoma at Dr Soetomo Hospital Surabaya. African Journal of Infectious Diseases 12, 7-12.
  13. Molijn A, Jenkins D, Chen W, et al (2016). Chinese HPV typing group: The complex relationship between human papillomavirus and cervical adenocarcinoma. Int J Cancer 138, 409-16.
  14. Ogura K, Ishi K, Matsumoto T, et al (2006). Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas. Pathol Int 56, 301-8.
  15. Panigoro R, Susanto H, Novel SS, et al (2013). HPV genotyping linear assay test comparison in cervical cancer patients: Implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia. Asian Pac J Cancer Prev 14, 5843-7
  16. Pirog EC (2017). Cervical adenocarcinoma: Diagnosis of human papillomavirus-positive and human papillomavirus-negative tumors. Arch Pathol Lab Med 141, 1653-67
  17. Schellekens MC, Dijkman A, Aziz MF, et al (2004). Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 93, 49-53.
  18. Siriaunkgul S, Utaipat U, Suthipintawong C, et al (2013). HPV genotyping in adenocarcinoma of the uterine cervix in Thailand. Int J Gynaecol Obstet 123, 226-30
  19. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high grade cervical lesions: A meta-analysis update. International Journal of Cancer 121, 621-632.
  20. Stolnicu S, Barsan I, Hoang L, et al (2018). International endocervical adenocarcinoma criteria and classification (IECC): A New pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 42, 214-226
  21. Tobing MD, Sahiratmadja E, Dinda M, et al (2014). Human papillomavirus genotypes profile in cervical cancer patients at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. Asian Pac J Cancer Prev 15, 5781-5.
  22. Horst vdJ, Siebers AG, Bulten J, et al (2017). Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013. Cancer Med 6, 416-423.
  23. Vet JNI, de Boer MA, van den Akker BEWM, et al (2008). Prevalence of human papillomavirus in Indonesia: A population-based study in three regions. British Journal of Cancer 99, 214–218.
  24. Wang X, Zeng Y, Huang X, et al (2018). Prevalence and genotype distribution of human papillomavirus in invasive cervical cancer, cervical intraepithelial neoplasia, and asymptomatic women in Southeast China. Biomed Res Int 8, 1-10.
  25. Zaravinos A, Mammas IN, Sourvinos G, et al (2009). Molecular detection methods of human papillomavirus. The International Journal of Biological Markers 24, 215-222
  26. Zhang X, Lv Z, Xu X, et al (2020). Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery. BMC Cancer 20, 1-10.

Most read articles by the same author(s)